This drug can reduce breast cancer recurrence
London: Zoledronic acid, a group of drugs, tried out on breast cancers among post-menopausal women has shown promising results.
Mainly used to treat osteoporosis, zoledronic acid is also given to cancer patients to protect against the effects of secondary bone cancer, such as pain and weakness in the bones.
Lab studies have suggested that zoledronic acid might also have direct anti-tumour effects and enhance other chemotherapy treatments.
Led by Robert Coleman, professor at the Weston Park Hospital in Sheffield, Britain, the drug trial recruited 3,360 patients with stage II/III breast cancer from 174 centres.
They were randomised to receive chemotherapy and/or endocrine therapy, with or without zoledronic acid, according to a Weston statement.
An interim analysis confirmed the overall survival rate was 85 percent compared to 79 percent for women who did not receive zoledronic acid.
"This is a small but significant increase," Coleman explains. These findings were presented at the 2011 European Multidisciplinary Cancer Congress.
More from India
More from World
More from Sports
More from Entertaiment
- Trump-Sharif conversation: Team Donald denies Pakistan's claims
- Aware of Chinese submarine deployment at Balochistan's Gwadar port, says Navy chief
- Like SAARC, should India boycott Pak in Heart of Asia conference?
- Hizbul commander Musa issues threats of attacks in new video
- 'Heart of Asia' Conference begins in Amritsar; Sartaj Aziz to pay a visit on Sunday
- Gujarat businessman declares highest ever black money amount – Rs 13,000 crore!
- Army proves Mamata Banerjee wrong, releases letter showing West Bengal govt knew of exercise
- Rs 14,000 crore default case: Gujarat businessman detained, says money belongs to politicians, babus
- Manohar Parrikar exposes Mamata's attempt to politicise routine Army exercise in Kolkata
- Newly-wed couple Yuvraj Singh and Hazel Keech perform `bhangra` at Goa airport – Viral video